calcium gluceptate Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Calcium gluceptate (also known as calcium glucoheptonate) was used, as calcium supplements by people who were unable to get enough calcium or who was needed it more. This drug was used to prevent and to treat several conditions, related to the hypocalcemia (not enough calcium in the blood). The body needs calcium to make strong bones; it is also needed for the heart, muscles, and nervous system to work properly. Nevertheless, that use of calcium gluceptate was discontinued.   NCATS

Chemistry

  • SMILES: O=C([O-])C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Ca+2]
  • InChIKey: FATUQANACHZLRT-KMRXSBRUSA-L
  • Mol. Mass: 490.42
  • ALogP: Missing data
  • ChEMBL Molecule:
    calcium gluceptate  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

alpha-glucoheptonic acid | alpha-glucoheptonic acid, calcium salt (2:1) | alpha-glucoheptonic acid, calcium salt (2:1), heptahydrate | alpha-glucoheptonic acid, magnesium salt (2:1) | alpha-glucoheptonic acid, potassium salt | alpha-glucoheptonic acid, sodium salt | calcii glucoheptonas | calcii glugoheptonas | calcium (2xi)-d-gluco-heptonate | calcium bis[(2xi)-d-glycero-d-gulo-heptonate] | calcium bis[(2xi)-d-glycero-d-ido-heptonate] | calcium bis[(3r,4s,5r,6r)-2,3,4,5,6,7-hexahydroxyheptanoate] | calcium gluceptate | calcium glucoheptonat | calcium glucoheptonate | calcium glucoheptonate (1:2) | calcium heptagluconate | copper glucoheptonate | d-glycero-d-gulo-heptonic acid | glucoheptonate | glucoheptonate de calcium | glucoheptonato calcico | glucoheptonic acid | trimethylene chlorobromide

Organizations (3)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Hypocalcemia (approved 1972)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue